| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/21/2010 | CA2730477A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730063A1 Compositions and methods of use for therapeutic antibodies |
| 01/21/2010 | CA2728616A1 Piperidyl acrylamide antogonists of ccr2 |
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/21/2010 | CA2726460A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/20/2010 | EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/20/2010 | EP2144871A1 Amidation process for the preparation of cathepsin k inhibitors |
| 01/20/2010 | EP2144613A2 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581576C Medicine for treating nonunion of bone and method for preparing the same |
| 01/20/2010 | CN100581575C Cervical spondylosis treating medicine and its preparation |
| 01/20/2010 | CN100581541C Utilization of extracts from racemosa rhizoma for producing estrogen-like organ-selective medicament for suppressing LHSP activity |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648992 Metalloproteinase 9 and/or 12 inhibitors; such as 5-({[4-[(2-cyclopropylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H1)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; synthesis; asthma, chronic obstructive pulmonary disease |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | CA2641571C Treatment of osteoarthritis |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010006260A1 Methods of use of eggshell polypeptides |
| 01/14/2010 | WO2010006184A2 Small-molecule inhibitors of hif and angiogenesis |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005322A1 Methods and compositions for promoting bone growth |
| 01/14/2010 | WO2010005133A1 Manufacturing method of collagen gel composition for bone regeneration |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010005004A1 Xanthine oxidase inhibitor and uric acid production inhibitor |
| 01/14/2010 | WO2010004761A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | WO2010004512A2 Dicabba-analogues of octreotide |
| 01/14/2010 | WO2010004283A2 Therapy |
| 01/14/2010 | WO2010003601A1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 01/14/2010 | WO2009144569A3 Hydrogel capable of containing and conveying cells |
| 01/14/2010 | US20100010222 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 01/14/2010 | US20100010014 Aminopyrimidine compounds and methods of use |
| 01/14/2010 | US20100010009 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009948 Combined calcium, magnesium and vitamin D supplements |
| 01/14/2010 | US20100009947 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100009911 Osteogenic synergic composition |
| 01/14/2010 | US20100008967 Bioactive scaffolds |
| 01/14/2010 | US20100008929 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 01/14/2010 | US20100008918 Methods for dosing an actriib antagonist and monitoring of treated patients |
| 01/14/2010 | CA2766828A1 Methods and compositions for promoting bone growth |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730664A1 Methods of use of eggshell polypeptides |
| 01/14/2010 | CA2730420A1 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 01/14/2010 | CA2730270A1 Dicarba-analogues of octreotide |
| 01/14/2010 | CA2730085A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143433A1 Preparation for the prevention of joint disease |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142664A1 Estimation and biological consequences of oxidative metabolism |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142224A2 Fibrin compositions containing strontium compounds |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1360500B1 Methods for selective targeting |
| 01/13/2010 | EP1339744B1 Production of recombinant bmp-2 |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579573C Chinese medicine composition orally taken for curing cervical vertebra osteoproliferation |
| 01/13/2010 | CN100579564C Medicine for curing gout and its preparing method |
| 01/13/2010 | CN100579560C Orally take Chinese medicine composition for treating rheumatoid arthritis |
| 01/13/2010 | CN100579551C Medicine for treating wind-damp arthralgia and hyperosteogeny |
| 01/13/2010 | CN100579546C Chinese medicinal liquid for treating rheumatic arthritis and rheumatoid arthritis |
| 01/13/2010 | CN100579541C Medicinal liquor for treating rheumatism and rheumatoid diseases |
| 01/13/2010 | CN100579537C Centella soft capsule and its preparing method |
| 01/13/2010 | CN100579524C Method of preparing simvastatin sustained-release microsphere carried series |
| 01/12/2010 | US7645796 Amino acid composition promoting collagen synthesis |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645601 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001946A1 Triazole derivative or salt thereof |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001258A2 Inhibition of tumour growth and metastases |
| 01/07/2010 | WO2010001185A1 Thieno [2,3-b] pyridine compounds with mglur activity |
| 01/07/2010 | WO2010001096A2 Treatment |
| 01/07/2010 | WO2010000851A2 Methods for modulating angiogenesis via dystrophin dp71 |